P2.05-047 Feasibility Study: Assessment of RT Dose Using Cardiac MRI Contouring Methodology on Retrospective Lung Planning CT Scans (original) (raw)
Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio
Chihaya Koriyama
The British journal of radiology, 2018
View PDFchevron_right
Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy
Sushma Agrawal
South Asian Journal of Cancer, 2014
View PDFchevron_right
The relationship between dosimetric factors, side effects, and survival in patients with non–small cell lung cancer treated with definitive radiotherapy
Deniz Sigirli
Medical Dosimetry, 2017
View PDFchevron_right
Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis
Pehr Lind
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy
Andrew Jackson
International Journal of Radiation Oncology Biology Physics, 2002
View PDFchevron_right
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis
Lionel Falchero
Radiotherapy and Oncology, 2004
View PDFchevron_right
Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy
Lone Hoffmann
Radiotherapy and Oncology, 2022
View PDFchevron_right
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy
P. Milecki
Neoplasma, 2005
View PDFchevron_right
Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors
D. Kannarunimit
Technology in Cancer Research & Treatment, 2015
View PDFchevron_right
Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
Anthony Yip
Cureus, 2020
View PDFchevron_right
Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours
Naoko Sanuki
British Journal of Radiology, 2012
View PDFchevron_right
Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients
Lone Hoffmann
Acta Oncologica, 2015
View PDFchevron_right
A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience
Chandana Reddy
Journal of Thoracic Oncology, 2009
View PDFchevron_right
Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends
Adam Maciejczyk
Reports of Practical Oncology & Radiotherapy, 2014
View PDFchevron_right
Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
Michael van Kampen
2001
View PDFchevron_right
Pulmonary function changes after radiotherapy in non–small-cell lung cancer patients with long-term disease-free survival
Sjaak Burgers
International Journal of Radiation Oncology*Biology*Physics, 2005
View PDFchevron_right
Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy
José Belderbos
Radiotherapy and Oncology, 2014
View PDFchevron_right
Guideline for Radiotherapy with Curative Intent in Patients with Early-Stage Medically Inoperable Non-Small-Cell Lung Cancer
Conrad Falkson
Current Oncology, 2017
View PDFchevron_right
Higher Biologically Effective Dose of Radiotherapy is Associated with Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated with Chemoradiation: An Analysis of the Radiation Therapy Oncology Group
Benjamin Movsas
Fuel and Energy Abstracts, 2000
View PDFchevron_right
Influence of tumor volume on survival in patients irradiated for non--small-cell lung cancer* 1
Lawrence Marks
International Journal of …, 2002
View PDFchevron_right
Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non–small-cell lung cancer
Wolfgang Schlegel, Ina Kyas, Juergen Debus
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer
Chandana Reddy
Journal of Thoracic Oncology, 2009
View PDFchevron_right
Dose-Intensive Thoracic Radiation Therapy for Patients at High Risk with Early-Stage Non–Small-Cell Lung Cancer
Jeffrey Bogart
Clinical Lung Cancer, 2005
View PDFchevron_right
Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy
Ritsuko Komaki
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Non-small cell lung cancer in stages I-IIIb: Long-term results of definitive radiotherapy with doses ≥ 80 gy in standard fractionation
Felix Sedlmayer
2010
View PDFchevron_right
Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study
Angela Van Baardwijk, Geert Bosmans
International Journal of Radiation Oncology*Biology*Physics, 2006
View PDFchevron_right
New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy
Lone Hoffmann
Acta Oncologica, 2015
View PDFchevron_right
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
Suneetha Devpura
Clinical and Translational Radiation Oncology
View PDFchevron_right
Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)
Catherine Legrand
European Journal of Cancer, 2007
View PDFchevron_right
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy
Michel van Den Heuvel
Radiotherapy and Oncology, 2009
View PDFchevron_right
Time Trends in Nodal Volumes and Motion During Radiotherapy for Patients With Stage III Non-Small-Cell Lung Cancer
Geert Bosmans
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
Influence of tumor volume on survival in patients irradiated for non—small-cell lung cancer
Su-min Zhou
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non–Small-Cell Lung Cancer
Constantin Yiannoutsos
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
A Collaborative Analysis of Stereotactic Lung Radiotherapy (Lung SBRT) Outcomes for Stage I Non-small Cell Lung Cancer (NSCLC) using Daily Online Cone-beam CT Image-guided Radiotherapy (CBCT-IGRT)
José Belderbos
International Journal of Radiation Oncology*Biology*Physics, 2010
View PDFchevron_right
Clinical and Dosimetric Predictors of Radiation Pneumonitis in a Large Series of Patients Treated With Stereotactic Body Radiation Therapy to the Lung
S. Sarangkasiri
International Journal of Radiation Oncology*Biology*Physics, 2013
View PDFchevron_right